TRENT-001: A phase II study of PD-1 inhibitors plus chemotherapy as induction therapy in patients with poorly differentiated locally advanced head and neck squamous cell carcinoma
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Ding Y.,Chen X.,Li Z.,et al.TRENT-001: A phase II study of PD-1 inhibitors plus chemotherapy as induction therapy in patients with poorly differentiated locally advanced head and neck squamous cell carcinoma[J].ANNALS OF ONCOLOGY.2024,35:doi:10.1016/j.annonc.2024.10.484.
APA：
Ding, Y.,Chen, X.,Li, Z.,Li, P.,Xu, H....&Zhou, J..(2024).TRENT-001: A phase II study of PD-1 inhibitors plus chemotherapy as induction therapy in patients with poorly differentiated locally advanced head and neck squamous cell carcinoma.ANNALS OF ONCOLOGY,35,
MLA：
Ding, Y.,et al."TRENT-001: A phase II study of PD-1 inhibitors plus chemotherapy as induction therapy in patients with poorly differentiated locally advanced head and neck squamous cell carcinoma".ANNALS OF ONCOLOGY 35.(2024)
医学